Loading organizations...
§ Private Profile · Aachen, Nordrhein-Westfalen, Germany
Develops MOBYBOX®, the world's smallest portable ECMO system for critical care, supporting heart and lung function in a 1kg self-contained device.
Hemovent GmbH, based in Aachen, Germany, develops the MOBYBOX® system, the world's smallest fully portable ECMO unit designed to support heart and lung function. This medical device, weighing approximately 1kg, provides mobile and cost-effective treatment for patients with respiratory or circulatory failure, reducing the therapy footprint by 90%. Prior to its acquisition, the pre-revenue medtech startup raised a $6 million Series A round, with MIG Capital as a lead investor. In 2021, Hemovent, which previously reported 6 employees, was acquired by MicroPort Scientific Corporation for up to €123 million, now operating as a wholly-owned subsidiary. The MOBYBOX® system holds CE Mark approval and is commercially available in Europe, with Christof Lenz serving as CEO. Hemovent was founded in 2013 by Dr. Oliver Marseille.
Hemovent has raised $19.8M across 5 funding rounds.
Hemovent has raised $19.8M in total across 5 funding rounds.
Hemovent has raised $19.8M across 5 funding rounds. Most recently, it raised $5.5M Series B Extension in July 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 7, 2020 | $5.5M Series B Plus | Matthias Guth | — | Announced |
| Feb 14, 2019 | $5.2M Series B | — | — | Announced |
| Jul 25, 2017 | $2.3M Series A Plus | — | KFW, MIG Capital, NRW.BANK, Seed Fonds Aachen | Announced |
| Apr 24, 2017 | $810K Grant | German Government | — | Announced |
| Feb 10, 2016 | $6M Series A | Matthias Guth | KFW, NRW.Venture, PB Beteiligung UND Vermoegensverwaltung, Seed Fonds Aachen, Wcti Partners | Announced |
Hemovent has raised $19.8M in total across 5 funding rounds.
Hemovent's investors include Matthias Guth, KfW, MIG Capital, NRW.BANK, Seed Fonds Aachen, German government, NRW.Venture, PB Beteiligung- und Vermoegensverwaltung, WCTI Partners.